MIST - Milestone Pharmaceuticals, Inc. Qarzning balans kapitallashuviga nisbati

Milestone Pharma (MIST) kompaniyasining korporativ logotipi

Ushbu grafikda aks etgan narxlar tendentsiyasi Milestone Pharmaceuticals (MIST) dinamikasini namoyish etadi, uning faoliyati dori ishlab chiqarish va sinovlarini tashqi pudratchilarga autsorsing qilishga tayanadi va ko'rsatkich 8.24 darajasida turibdi. Biznes kardiomolekulalarni kashf etishga yo'naltirilgan bo'lib, u uchinchi tomon provayderlarining ishonchliligiga kuchli bog'liq holda qolmoqda. Yangi tadqiqotlarga bo'lgan barqaror qiziqish kompaniyani global iqtisodiy tebranishlardan mustaqil ravishda ishlaydigan defensiv aktivga aylantiradi.

Qarzning balans kapitaliga nisbati: Milestone Pharmaceuticals (MIST) 04.07.2022 - 27.10.2026 uchun

Milestone Pharmaceuticals, Inc. (MIST) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Milestone Pharmaceuticals|MIST - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Milestone Pharmaceuticals Inc|MIST - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati Milestone Pharmaceuticals|MIST - Jami sof aktivlar|Bozor qiymatining balans qiymatiga nisbati milestonepharma.com|MIST - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Milestone Pharmaceuticals|MIST - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Milestone Pharma|MIST - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Milestone Pharmaceuticals Inc
Kompaniyaning fundamental tahlili:Milestone Pharmaceuticals - MIST
Milestone Pharma brendining mahsuloti

Kardiologiya bo'yicha tadqiqot xarajatlari asosan qarz kapitali xarajatlariga bog'liq bo'lgan Milestone Pharmaceuticals (MIST) uchun kredit yuki nazorati hayotiy muhim omildir. Jami qarzdorlikning o'z kapitaliga nisbatini tahlil qilish orqali investor barcha majburiyatlar va kapital o'rtasidagi bog'liqlikni baholaydi, bu esa haddan tashqari kredit yuklamasi xavfini real vaqt rejimida baholash imkonini beradi va emitentning moliyaviy barqarorligini tasdiqlaydi.

Milestone Pharmaceuticals kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar REGN (Regeneron Pharmaceuticals)|irhythmtech.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Lantheus (LNTH)|Mineralys (MLYS) - Qarzning sof aktivlarga nisbati|HTFL - Qarzning balans qiymatiga nisbati|KMTS (Kestra Medical Corp) - Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati ESPR|Qarzning balans qiymatiga nisbati amarincorp.com|AVR (Anteris Technologies Global) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar TNYA (tenayatherapeutics.com)|Qarzning balans kapitallashuviga nisbati CVRx, Inc CVRX|Qarzning balans kapitallashuviga nisbati Cardiol Therapeutics Inc CRDL|BEAT (HeartBeam, Inc.) - Balans kapitallashuviga qarzlar|TENX: Balans qiymatiga qarzlar|Adagio Medical - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar BioCardia Inc.|Catheter Precision Corp (VTAK) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati ABIO|Acasti Pharma - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar AVTE (aerovatetx.com)|VERV - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Windtree Therapeutics Inc. WINT